Our target list for the US

Ranked accounts

This is the value we can capture now, and how to target them. Exposure is total pain carried: trials run times their average pain. Mean pain is whose mix sits in the hardest cells. Novartis tops both; below it, they diverge.

454,031registered trials

161,954with a US site

52,660pharma-run, in scope

750sponsors ranked (≥ 8 trials)

exposure = US industry trials × mean pain of their trial mixA big portfolio in easy cells and a small one in hard cells are different kinds of account, so both factors are shown in the table.

Click any column to sort.


1	Novartisconcentrated	103,719	1,501	257	69	Oncology 508Cardiovascular 190Immunology & Inflammation 115
2	Pfizer	85,139	1,696	339	50	Oncology 403Healthy Volunteers 277Infectious Disease 198
3	GlaxoSmithKline	69,479	1,306	136	53	Infectious Disease 302Oncology 251Respiratory 202
4	Eli Lilly and Company	69,278	1,340	119	52	Oncology 359Endocrine & Metabolic 243Healthy Volunteers 222
5	AstraZenecaconcentrated	67,190	1,215	99	55	Oncology 388Endocrine & Metabolic 193Respiratory 135
6	Hoffmann-La Rocheconcentrated	56,485	869	106	65	Oncology 338Infectious Disease 101Immunology & Inflammation 68
7	Bristol-Myers Squibbconcentrated	55,354	943	129	59	Oncology 393Infectious Disease 136Healthy Volunteers 122
8	Sanoficoncentrated	42,251	687	106	62	Oncology 156Endocrine & Metabolic 99Cardiovascular 68
9	Amgenconcentrated	33,764	549	94	62	Oncology 170Immunology & Inflammation 100Endocrine & Metabolic 64
10	Merck Sharp & Dohme LLCconcentrated	31,860	557	39	57	Oncology 243Infectious Disease 106Healthy Volunteers 77
11	Janssen Research & Development, LLCconcentrated	31,807	569	66	56	Oncology 181Immunology & Inflammation 99Healthy Volunteers 98
12	AbbVieconcentrated	30,400	517	80	59	Oncology 164Immunology & Inflammation 82Healthy Volunteers 65
13	Boehringer Ingelheimconcentrated	27,999	469	56	60	Respiratory 101Oncology 95Endocrine & Metabolic 58
14	Bayerconcentrated	27,604	412	57	67	Oncology 153Cardiovascular 40Hematology 35
15	Gilead Sciencesconcentrated	27,188	489	102	56	Infectious Disease 247Oncology 115Immunology & Inflammation 38
16	Celgene	23,150	336	74	69	Oncology 219Healthy Volunteers 50Immunology & Inflammation 26
17	Genentech, Inc.	20,287	316	32	64	Oncology 161Healthy Volunteers 38Immunology & Inflammation 29
18	Takeda	19,650	393	67	50	Healthy Volunteers 72Immunology & Inflammation 46Endocrine & Metabolic 46
19	Novo Nordisk A/S	17,658	405	26	44	Endocrine & Metabolic 284Hematology 65Cardiovascular 13
20	Eisai Inc.	17,357	285	33	61	Oncology 110Neurology 56Healthy Volunteers 44
21	Daiichi Sankyo	16,520	234	25	71	Oncology 132Cardiovascular 36Endocrine & Metabolic 17
22	Regeneron Pharmaceuticals	15,686	261	40	60	Oncology 77Cardiovascular 36Healthy Volunteers 22
23	Incyte Corporation	15,505	236	64	66	Oncology 133Dermatology 46Immunology & Inflammation 21
24	Biogen	15,419	285	58	54	Neurology 91Healthy Volunteers 60Oncology 37
25	UCB	14,405	215	23	67	Neurology 97Immunology & Inflammation 75Healthy Volunteers 16

How to read thisExposure ranks who the pain lands on, not who is likeliest to buy. A sponsor high on exposure but average on mean pain is a volume play; one high on both is concentrated in the hard cells and carries a concentrated tag. Contract research organizations, the firms sponsors hire to run trials, are not shown, because the registry does not record them reliably. Methodology.